Avaulta vaginal mesh complications | Tim Miles Law Offices has been used in the treatment of stress urinary incontinence. While the FDA has only issued warnings about Avaulta vaginal mesh, the potential risks are similar to those of other meshes. Although the FDA has issued only warnings for the vaginal mesh itself, similar complications may also occur with transvaginal mesh. These complications can be treated by removing the mesh or replacing it with another one.

Consider Other Treatment Options Before Using This Mesh

While the Avaulta vaginal mesh has been widely praised for its long-lasting, painless appearance, and low risk of infection, complications have occurred. The FDA’s public health notification was based on data collected from nine manufacturers of surgical mesh. Even after the FDA issued its warning, the number of adverse events increased. The FDA also asked surgeons to consider other treatment options before using this mesh.

However, the risks associated with Avaulta mesh are similar to those of the pelvic mesh recalled more than a decade ago. If the mesh has similar problems, the FDA should not have approved it. It is the duty of the manufacturers of surgical mesh to ensure that their products are properly designed, tested, and manufactured. This is true for all types of mesh. While meshes may be helpful in some cases, women with other conditions are at greater risk of complications.

Avaulta vaginal mesh lawsuits have been the subject of several bellwether trials. The FDA issued warnings about Avaulta mesh implants in 2008 and 2011. Bard pulled the mesh implant from the market in 2012 after several lawsuits were filed. As a result, a California jury awarded a woman $5.5 million after discovering she had complications. The nurse had to undergo three surgeries in order to correct her urinary problems.